RARE vs TREE · rev $560.2M vs P/E 2.8, rev $900.2M
Ultragenyx (RARE) versus Lendingtree Inc (TREE) — a side-by-side from cached financials, not a winner call.
Ultragenyx (RARE) is a biotechnology company listed on US.
Lendingtree Inc (TREE) is a financial conglomerates company listed on NASDAQ.
Latest reported RARE revenue for 2024-12-31 was $560.2M. Net income was -$569.2M. Revenue was up 29.0% from 2023-12-31 to 2024-12-31. RARE currently screens at market cap $2.79B.
Latest reported TREE revenue for 2024-12-31 was $900.2M. Net income was -$41.7M. Revenue was up 33.9% from 2023-12-31 to 2024-12-31. TREE currently screens at market cap $499.8M and trailing P/E 2.8.
RARE currently screens at market cap $2.79B. TREE currently screens at market cap $499.8M and trailing P/E 2.8.
Not investment advice. Open the RARE and TREE stock pages for the full models.
Not investment advice.